EUVIMEDEUVIMED entdecken
Crossref

Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance

S Sean Tu iD, Jaime King iD

New England Journal of Medicine · 23.04.2026 · 394 (16) · 1563-1565

DOI: 10.1056/nejmp2516842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 23.04.2026. Verfasst von S Sean Tu und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama School of Law, Tuscaloosa. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • University of Alabama School of Law, Tuscaloosa.
  • Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
  • Faculty of Law, University of Auckland, Auckland, New Zealand.

ORCID-Profile: S Sean Tu, Jaime King

Zitieren

APA

Tu, S. S., & King, J. (2026). Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance. New England Journal of Medicine, 394(16), 1563-1565. https://doi.org/10.1056/nejmp2516842

Vancouver

Tu SS, King J. Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance. New England Journal of Medicine. 2026;394(16):1563-1565. doi:10.1056/nejmp2516842

BibTeX
@article{Tu2026,
  author = {Tu, S Sean and King, Jaime},
  title = {Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {16},
  pages = {1563--1565},
  doi = {10.1056/nejmp2516842}
}
Kostenlos starten →